Lidocaine Hydrochloride Jelly
Product Images NDC 76329-3011

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 76329-3011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by International Medication Systems, Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lidocaine Jelly 01)

Chemical structure diagram of Lidocaine Hydrochloride, showing its molecular arrangement including aromatic ring, methyl groups, amide linkage, diethylamino group, and hydrochloride component as indicated by the 'HCl' symbol.*

FDA Label Image

Figure (Lidocaine Jelly 02)

An instructional illustration showing two hands holding and removing the cap from a prefilled tube or applicator, likely demonstrating how to open or prepare a topical jelly product for use.*

FDA Label Image

Figure (Lidocaine Jelly 03)

An instructional diagram showing a hand holding a syringe-like dispenser with an applicator tip, demonstrating how to use the device, likely for applying topical lidocaine hydrochloride jelly.*

FDA Label Image

Figure (Lidocaine Jelly 04)

An instructional black-and-white line drawing showing a hand holding a tube of medication with the cap removed. The separate image of the cap is labeled 'Cap off.' The illustration appears to demonstrate how to remove the cap from a medication tube, likely for topical application.*

FDA Label Image

Principal Display Panel (5 mL Label)

Label for Lidocaine Hydrochloride Jelly USP 2%, 20 mg/mL (100 mg total) topical jelly in a 5 mL sterile pak by International Medication Systems, Limited. The label includes dosage instructions, storage conditions, and syringe assembly directions. It specifies single use, no preservatives added, and sterile packaging.*

FDA Label Image

Principal Display Panel (10 mL Label)

Label for Lidocaine Hydrochloride Jelly USP 2%, containing 20 mg/mL, topical jelly in a 10 mL Sterile Pak Uro-Jet by International Medication Systems, Limited. The label includes directions for use, storage conditions, and notes on sterility and syringe assembly instructions.*

FDA Label Image

Principal Display Panel (20 mL Label)

Label of Lidocaine Hydrochloride Jelly USP 2%, containing 400 mg (20 mg/mL) in a 20 mL sterile pack by International Medication Systems, Limited. The label states the jelly is for topical use only and includes directions for use with a Uro-Jet syringe. Storage instructions and formulation details are also visible.*

FDA Label Image

Principal Display Panel (20 mL Label)

Label for Lidocaine Hydrochloride Jelly USP, 2% (20 mg/mL), 5 mL sterile pack by International Medication Systems, Limited. The label specifies topical use, single-dose sterile packaging, and instructions for aseptic technique during syringe assembly. It also includes dosage form details, storage conditions, and manufacturer location.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.